Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

By Caubet J.-F.   Tosteson T.D.   Dong E.W.   Naylon E.M.   Whiting G.W.   Ernstoff M.S.   Ross S.D.  

Urology, Vol. 49, Iss. 1, 1997-01 ,pp. : 71-78

Elsevier

Access to resources Recommend Favorite

Combined androgen blockade for the treatment of metastatic cancer of the prostate

By Schellhammer P.F.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 622-628

Elsevier

Access to resources Recommend Favorite

Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failed - a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

By Ornstein D.K.   Smith D.S.   Andriole G.L.  

Urology, Vol. 52, Iss. 6, 1998-12 ,pp. : 1094-1097

Elsevier

Access to resources Recommend Favorite

Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?

By Labrie F.   Candas B.   Gomez J.-L.   Cusan L.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 115-119

Elsevier

Access to resources Recommend Favorite

Pilot attempt of advanced prostate cancer treatment T3NxMx−1 by intermittent more complete androgen blockade

By Dutkiewicz Slawomir  

International Urology and Nephrology, Vol. 36, Iss. 3, 2004-09 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite